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Abstract Adrenal venous sampling (AVS) is generally
considered to be the gold standard in distinguishing uni-
lateral and bilateral aldosterone hypersecretion in primary
hyperaldosteronism. However, during AVS, we noticed a
considerable variability in aldosterone concentrations
among samples thought to have come from the right
adrenal glands. Some aldosterone concentrations in these
samples were even lower than in samples from the inferior
vena cava. We hypothesized that the samples with low
aldosterone levels were unintentionally taken not from the
right adrenal gland, but from hepatic veins. Therefore, we
sought to analyze the impact of unintentional cannulation
of hepatic veins on AVS. Thirty consecutive patients
referred for AVS were enrolled. Hepatic vein sampling was
implemented in our standardized AVS protocol. The data
were collected and analyzed prospectively. AVS was suc-
cessful in 27 patients (90%), and hepatic vein cannulation
was successful in all procedures performed. Cortisol con-
centrations were not signiﬁcantly different between the
hepatic vein and inferior vena cava samples, but aldoste-
rone concentrations from hepatic venous blood (median,
17 pmol/l; range, 40–860 pmol/l) were markedly lower
than in samples from the inferior vena cava (median,
860 pmol/l; range, 460–4510 pmol/l). The observed dif-
ference was statistically signiﬁcant (P \ 0.001). Aldoste-
rone concentrations in the hepatic veins are signiﬁcantly
lower than in venous blood taken from the inferior vena
cava. This ﬁnding is important for AVS because hepatic
veins can easily be mistaken for adrenal veins as a result of
their close anatomic proximity.
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Introduction
In primary aldosteronism (PA), the choice of treatment
depends on the lateralization of aldosterone secretion. In
cases with unilateral aldosterone overproduction, adrenal-
ectomy leads to improvement or even a complete cure of
high blood pressure. Therefore, it is important to differ-
entiate between bilateral and unilateral forms of PA [1, 2].
The only diagnostic method that can recognize unilate-
ral aldosterone hypersecretion is adrenal venous sampling
(AVS) [3, 4]. The adequacy of adrenal blood sampling is
evaluated by the ratio of cortisol concentrations in the
adrenal vein and in the inferior vena cava (Cadrenal/Civc).
The higher the Cadrenal/Civc is, the less is the dilution of
blood from adrenal veins, which results in a more repre-
sentative sample of adrenal venous blood. The published
criteria for appropriate adrenal vein sampling range from
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The ratio of aldosterone to cortisol (AC) is the param-
eter used to compare both adrenals in order to eliminate
variable dilution of adrenal venous blood. The lateraliza-
tion of aldosterone secretion is assessed by the ratio
ACdominant adrenal/ACnondominant adrenal. The reported criteria
for abnormal lateralization of aldosterone secretion
also vary signiﬁcantly, with the ratio ACdominant adrenal/
ACnondominant adrenal varying from C2t oC5[ 7]. Moreover,
some centers require the suppression of the nondominant
adrenal glands (ACnondominant adrenal \ ACivc) to conﬁrm
abnormal lateralization of aldosterone secretion [8].
When analyzing the AVS results of some patients, we
noticed considerable variability in aldosterone concentra-
tions among samples thought to have come from the right
adrenal glands. Table 1 presents the AVS data of one such
patient as an example. These ﬁndings raised doubts about
the validity of some of our AVS examinations.
Repeated measurements of hormone concentrations in
individual samples excluded laboratory errors. Instead, we
hypothesized that some right adrenal samples were actually
taken not from adrenal glands but from hepatic veins,
which are located nearby. To avoid any further confusion,
we implemented hepatic vein sampling into our routine
standardized AVS protocol. This approach was chosen
primarily to explain the data acquired from individual
patients. By using these methods, we were able to sys-
tematically analyze the origin of the aldosterone variability
among samples thought to come from the right adrenals.
Materials and Methods
Data from 30 consecutive patients referred to AVS were
analyzed. The patients’ characteristics are shown in
Table 2.
Indication of AVS resulted from a high clinical suspi-
cion of PA, which was based on a previous noninvasive
diagnostic workup. Withdrawal of aldosterone antagonists
for 2 months was required before the procedures were
initiated. The ratio of aldosterone to active renin concen-
tration (ARR) was used to screen patients for PA. Blood
sampling for ARR was always performed in the morning
hours (7–10 a.m.) with the patients in the upright position
for at least 30 min before sample collection. For calcula-
tion of ARR, both serum aldosterone and plasma renin
concentrations were expressed in ng/l. ARR values of[20
were considered to be abnormal, and on the basis of our
observations in 69 healthy volunteers (unpublished data),
20 was set as the cutoff value. Before sampling for ARR,
no speciﬁc changes in antihypertensive medication were
initially required (except for the withdrawal of any aldo-
sterone antagonists as mentioned above).
However, if the patient had an ARR of [20, adrenal
adenoma,orhypokalemia,ARRsamplingwasrepeatedafter
2 weeks of withdrawal from any medication that could
interfere with the renin–angiotensin–aldosterone system.
Table 1 AVS results of a patient with marked variability in aldosterone concentration in samples thought to come from the right adrenal vein
(see samples 2, 3, and 4)
Sample no. Sample identiﬁcation Aldosterone (pmol/l) Cortisol (nmol/l) Cadrenal/Civc AC Appropriate
adrenal sampling
a
1 Left adrenal vein 49,000 7,950 15.29 6.16 Yes
2 Right adrenal vein 390 930 1.79 0.42 No
3 Right adrenal vein 150 680 1.31 0.22 No
4 Right adrenal vein 47,800 8,100 15.58 5.90 Yes
5 Inferior vena cava
b 1,310 520 2.51
AVS adrenal venous sampling, AC ratio of aldosterone to cortisol concentration, Cadrenal/Civc ratio of the cortisol concentrations in the adrenal
vein and the inferior vena cava
a Appropriate adrenal sampling was deﬁned as Cadrenal/Civc values of[5
b A sample from the inferior vena cava was taken below the renal veins
Table 2 Principal characteristics of the study population
a
Characteristic Value
No. of patients (no. women) 30 (4)
Age (years) 52 (33–71)
Systolic blood pressure (mmHg) 133 (112–200)
Diastolic blood pressure (mmHg) 84 (68–110)
No. of antihypertensive drugs 4 (2–7)
Serum aldosterone (pmol/l)
b 510 (240–1070)
Plasma active renin (ng/l)
b 2.10 (0.48–7.15)
Aldosterone to renin ratio
c 77 (25–762)
a Values are expressed as median (range) unless otherwise indicated
b Screening values
c Ratio of aldosterone to renin concentration was calculated in con-
ventional units (ng/l)
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whowereconsideredatriskfromuncontrolledhypertension.
On the basis of persistent increase of ARR ([20), the
patients were referred for suppression testing. Verapamil
and doxazosin were the only antihypertensive drugs
allowed. Blood samples for serum aldosterone were taken
in the supine position after a 4-h saline infusion (2000 ml)
and a previous period of high salt intake. Aldosterone was
considered nonsuppressible when it was [100 pmol/l,
which, on the basis of our observations from 32 healthy
volunteers (unpublished data), was the cutoff value.
All AVS procedures were performed according to the
routine standardized protocol used in our center. No
changes in concomitant medications were required, except
for oral anticoagulants and aldosterone antagonists that had
to be withdrawn before the procedure. All of the patients
provided informed written consent for the AVS procedure
according to the following protocol. To minimize stress-
induced ﬂuctuations in adrenal hormones secretion, an
infusion of cosyntropin was administered 1 h before and
during the procedure, at the rate of 160 lg/h. The design of
the cosyntropin dosing scheme was inspired by previous
reports [9, 10].
Samples were taken step by step from both adrenal
veins, one of the hepatic veins, and the inferior vena cava
below the renal veins [11, 12]. Because cannulation of
adrenal veins, especially the right one, is technically dif-
ﬁcult, multiple samples were taken in order to increase the
success rate of the procedure.
Angiographic veriﬁcation of the catheter placement into
adrenal and hepatic veins was required both before and just
after the sampling in order to exclude the possibility of
catheter displacement during blood sampling [12]. Small
amounts of contrast agent were used to minimize the risk of
adrenal injury.
Aldosterone and cortisol concentrations were measured
in all the acquired samples. Commercially available
radioimmunoassay kits were used both to measure aldo-
sterone (Diagnostic Products Corporation, Los Angeles,
CA) and cortisol (Immunotech, Beckman Coulter, Mar-
seille, France). In the long term, the observed intra-assay
coefﬁcients of variation were less than 7% for aldosterone
and no more than 5% for cortisol. The cross-reactivity of
the diagnostic antibodies for other corticosteroids was low.
AVS was considered successful when samples with
Cadrenal/Civc values of [5 were obtained from both adre-
nals. Abnormal lateralization of aldosterone secretion was
deﬁned by ACdominant adrenal/ACnondominant adrenal values of
[4[ 5]. These criteria were chosen to avoid uncertainties
when indicating adrenalectomy.
All the patients provided written informed consent to the
AVS procedure according to the above-mentioned proto-
col. Institutional review board approval was not required.
Nonparametric tests were used for statistical analysis of
the acquired data (MedCalc, Mariakerke, Belgium).
Results
The AVS procedure was successful in 27 patients (90%)
when samples with a Cadrenal/Civc value of [5 were
obtained from both adrenals. One patient was catheterized
twice because the ﬁrst catheterization failed to yield ade-
quate samples. No complications were noted. By using
samples with the highest Cadrenal/Civc, a lateralization of
aldosterone secretion (ACdominant adrenal/ACnondominant adrenal
[4) was diagnosed in eight cases (26.7%).
Hepatic vein cannulation was successful in all AVS
procedures performed. The aldosterone concentration was
uniformly lower in hepatic veins than in the inferior vena
cava. The medians of aldosterone concentrations in hepatic
venous blood and the inferior vena cava were 170 (range,
40–860) pmol/l and 860 (range, 460–4510) pmol/l,
respectively (Fig. 1). The observed difference was highly
statistically signiﬁcant (P\0.001) by the Wilcoxon test.
In contrast, no signiﬁcant difference in the cortisol
concentrations was observed between hepatic veins (med-
ian, 810 nmol/l; range, 510–1 350 nmol/l) and inferior
vena cava (median, 790 nmol/l; range, 540–1 500 nmol/l).
In patients with successful AVS, the ratio of cortisol
concentrations in the hepatic vein and inferior vena cava
(Chepatic/Civc) was calculated as a parameter, in a manner
analogous to Cadrenal/Civc. Marked variability in Chepatic/Civc
was noted (range, 0.74–2). In eight patients (29.6%), the
Chepatic/Civc value was B0.9, and in seven patients (25.9%),
the Chepatic/Civc value was C1.1.
Fig. 1 Aldosterone concentrations in the HV and in the IVC. Graph
compares the aldosterone concentrations in the HV and in the IVC.
Aldosterone concentration in HV was uniformly and signiﬁcantly (P
\0.001) lower than in the IVC. HV hepatic vein, IVC inferior vena
cava
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been considered to be from the right adrenal, the lowest
published criterion for appropriate AVS [6] would have
been satisﬁed.
Replacing the right adrenal samples with the corre-
sponding hepatic samples with Chepatic/Civc values of C1.1
would have led to changes in the AVS interpretation in all
seven patients. In six patients without lateralization of
aldosterone secretion, false hypersecretion from the left
adrenal would have been detected. Moreover, in one
patient with right-side aldosterone overproduction, acci-
dental hepatic vein sampling would have masked the lat-
eralization of aldosterone secretion.
Discussion
Implementation of hepatic sampling into our routine AVS
protocol cleared up some of our doubts about the clinical
interpretation of the data acquired. By taking one addi-
tional control sample from the hepatic veins during AVS,
we were able to explain the observed discrepancies in
aldosterone concentrations among ‘‘right adrenal’’ venous
samples in individual patients.
When we analyzed the data from hepatic samples, we
observed that liver metabolism of aldosterone exceeded
that of cortisol. Aldosterone concentrations found in the
hepatic venous blood were only a fraction of those found in
the inferior vena cava, whereas cortisol levels were not
signiﬁcantly different. The high metabolic rate of aldoste-
rone in the liver is well known [13, 14]. However, to our
knowledge, it has not been mentioned in the context of
AVS. In particular, a low aldosterone concentration in the
hepatic venous blood may have implications for AVS
interpretation if a sample of hepatic venous blood is mis-
takenly thought to come from the right adrenal vein. Cor-
tisol concentration does not enable the differentiation of
adrenal and nonadrenal samples when the lowest recom-
mended Cadrenal/Civc cutoff criterion [15] is used. In a
quarter of the examined patients, the estimated cortisol
concentration in the liver was at least 10% higher than that
in the inferior vena cava. In our opinion, there are several
reasons that may explain this ﬁnding.
First, the most obvious explanation seems to be the
inherent imprecision of laboratory assays of cortisol. The
precision of a laboratory test describes a coefﬁcient of
variation that is deﬁned by the ratio of the standard
deviation (SD) to the mean. According to statistics, 68.3%
of values measured from one sample are within the range
of one SD from the mean, and 99.7% of measured values
are within the range of 3 SDs. Therefore, when the
coefﬁcient of variation of the cortisol laboratory assess-
ment is 5%, 31.7% of the measured values (from one
sample) lie more than ±5% away from the mean. Con-
sequently, it is not unlikely that the estimated cortisol
concentrations in two nonadrenal samples could differ by
more than 10%. Second, despite continuous cosyntropin
infusion during sampling, we remained unable to exclude
small ﬂuctuations in serum cortisol. These arguments
support the fact that the number of hepatic samples with
Chepatic/Civc values of C1.1(25.9%) corresponds to the
proportion of examinations (29.6%) with Chepatic/Civc
values of B0.9.
Adrenal samples containing a signiﬁcant portion of
nonadrenal blood can inﬂuence the results, especially when
they are contaminated with hepatic venous blood, which
has a low concentration of aldosterone. As a potential
cause, the anomalous conﬂuence of adrenal and hepatic
vein has been described [16]. However, the frequency and
the clinical signiﬁcance of this anomaly are poorly under-
stood [17, 18]. In our study, we did not systematically
assess adrenal venous anatomy. Retrograde venography
with a large volume of contrast agent would greatly
increase the risk of adrenal hemorrhage. Moreover,
venography itself cannot depict related parenchymatous
organs or differentiate anomalous hepatic veins from right
adrenal veins [19].
In practice, displacement of the catheter during sam-
pling can occur. High concentrations of adrenal hormones
can be found in the blood taken from the inferior vena cava
above the adrenal veins [18] because the laminar blood
ﬂow may prevent complete dilution of blood coming from
adrenal veins. However, this may also be true for blood
with a low concentration of aldosterone coming from
hepatic veins lying close to the adrenal veins.
We tried to eliminate this effect by performing adrenal
angiography not only before but also after sampling, but
adherence to this rule was not absolute. As an example, we
present AVS data of one patient in whom it was difﬁcult to
cannulate a right adrenal vein (Table 3). Inconsistently
with our protocol, not all samples were taken under pre-
deﬁned angiographic guidance. Cortisol-corrected aldo-
sterone concentrations (AC) differed greatly between
samples with moderate and high Cadrenal/Civc values.
Moreover, marked AC differences were observed among
samples with moderate Cadrenal/Civc values (Table 3, sam-
ples 2, 6, 7, and 8), which can be explained by variable
dilution of adrenal venous blood. In fact, as demonstrated
in Table 3, two samples ascribed to right adrenal veins
were taken not from the adrenal but from the liver
(Table 3, samples 3 and 4).
Therefore, the only principal determinant of successful
adrenal sampling is a high concentration of cortisol. The
recent guidelines on PA [20] report an adrenal/peripheral
vein cortisol ratio that is typically more than 10:1 with the
continuous cosyntropin infusion protocol, and more than
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criteria for adequate adrenal sampling, with or without
adrenal stimulation, are based primarily on local experi-
ence and personal opinions. They vary greatly from Cadre-
nal/Civc values of C1.1 [6]t oCadrenal/Civc values of[5[ 5].
It is unclear to what extent our ﬁndings are applicable to
AVS procedures performed without adrenal stimulation
[21, 22]. However, our data clearly show that appropriate
choice of a Cadrenal/Civc cutoff should at least eliminate the
inherent imprecision of cortisol laboratory estimation.
To conclude, we found that aldosterone concentration in
hepatic veins is uniformly lower than in mixed venous
blood taken from the inferior vena cava; however, no dif-
ference in cortisol concentrations was observed between
the two veins. This ﬁnding may have implications for AVS
because unintentional cannulation of hepatic veins instead
of right adrenal veins can occur during adrenal catheteri-
zation. Caution should be taken when samples character-
ized by only mild increase in cortisol concentration
(compared with inferior vena cava) are used for the inter-
pretation of the results.
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